On July 16, 2015, Mezzion Pharma Co.,Ltd. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7,380 KRW | +1.51% | +4.83% | -25.45% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-25.45% | 220M | |
-1.51% | 105B | |
+3.22% | 97.5B | |
+1.86% | 22.19B | |
-16.53% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.09% | 14.52B | |
+5.47% | 14.09B | |
+28.85% | 10.99B |
- Stock Market
- Equities
- A095700 Stock
- News Genexine, Inc.
- Mezzion Pharma Co.,Ltd. announced that it has received KRW 42 billion in funding from a group of investors.